# 16-Hour Fasting Plus Serplulimab and CAPEOX as Neoadjuvant Therapy in pMMR/MSS Advanced Mid-to-Low Rectal Cancer

> clinical trial · VERIFIED · 2026-08-21

Status: NOT_YET_RECRUITING · Sponsor: Zhejiang University · Condition: pMMR/MSS

- Company: Zhejiang University
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07779694

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.